Professor Rimma Axelsson was honoured in connection with TTA’s symposium

At the Theranostics Trial Alliance (TTA) symposium on 6 November, a special tribute session was held for Professor Rimma Axelsson ahead of her forthcoming retirement.
During the session, her important contributions to nuclear medicine, research and education were recognised. Speakers included Professor Håkan Geijer of Örebro University, Head of Operations Erik Samen from Nuclear Medicine and Hospital Physics, and our Head of the Department of Molecular Medicine and Surgery (MMK), Rebecca Hultgren.

Rimma Axelsson has been Professor of Nuclear Medicine since 2022 and is one of the initiators of the Theranostics Trial Alliance at Karolinska. She has made significant contributions to doctoral education and, as principal supervisor, has supervised nine doctoral students through to their doctoral defence. She is currently the principal supervisor for one further doctoral student and has also served as co-supervisor for several doctoral students.
The tribute session was an opportunity to recognise and thank Rimma Axelsson for her many years of commitment and valuable contributions to the development of nuclear medicine, in research as well as in education and clinical practice.